Lilly undertakes no duty to update forward-looking statements. P-LLY JD351100 1. Jentadueto® (linagliptin/metformin HCl) tablets. EMA Summary of Product Characteristics. 2012 2.

Linagliptin, which is marketed as Tradjenta ® (linagliptin) tablets in the U.S., is a once-daily, 5-mg tablet used along with diet and exercise to improve glycemic control in adults with type 2 ...

Empagliflozin/linagliptin tablets will be available in 10mg/5mg and 25mg/5mg strength tablets in 30-, 90-, and 1000-count bottles. For more information call (800) 542-6257 or visit Glyxambi.com.

5. Tradjenta™ (linagliptin) tablets. Highlights of Prescribing Information. Initial U.S. Approval: 2011. 6. Trajenta™ (linagliptin) tablets. EMA Summary of Product Characteristics.

Tradjenta is expected to be available in May 2011 in a 5mg dosage strength. For more information call (800) 542-6257 or visit www.tradjenta.com.

Linagliptin, which is marketed as Tradjenta® (linagliptin) tablets in the U.S., is a once-daily, 5-mg tablet used along with diet and exercise to improve glycemic control in adults with T2D.

Linagliptin, which is marketed as TRADJENTA ® (linagliptin) tablets in the U.S., is a once-daily 5-mg tablet used along with diet and exercise to improve glycemic control in adults with T2D.

Bioequivalence of linagliptin/metformin HCl was demonstrated with co-administered linagliptin and metformin tablets in healthy subjects with Type 2 Diabetes. 1,2 ...

The FDA has approved Tradjenta (linagliptin) tablets to control blood sugar in adults with diabetes type two - to be used along with diet and exercise, Boehringer Ingelheim Pharmaceuticals, Inc.

Glyxambi will be available in 10mg/5mg and 25mg/5mg strength tablets in 30-, 90-, and 1000-count bottles. For more information call (800) 542-6257 or visit Glyxambi.com.